Cargando…

The authors reply: Korean clinical practice guideline for benign prostatic hyperplasia

Detalles Bibliográficos
Autores principales:	Yeo, Jeong Kyun, Kim, Hyung Jee
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Korean Urological Association 2016
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4949692/ https://www.ncbi.nlm.nih.gov/pubmed/27437542 http://dx.doi.org/10.4111/icu.2016.57.4.305

Ejemplares similares

Korean clinical practice guideline for benign prostatic hyperplasia
por: Yeo, Jeong Kyun, et al.
Publicado: (2016)

Letter to the editor: Korean clinical practice guideline for benign prostatic hyperplasia
por: Jung, Jae Hung, et al.
Publicado: (2016)

The authors reply: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
por: Kabir, Ali, et al.
Publicado: (2015)

Clinical practice guideline for transurethral plasmakinetic resection of prostate for benign prostatic hyperplasia (2021 Edition)
por: Zeng, Xian-Tao, et al.
Publicado: (2022)

Prostatitis and benign prostatic hyperplasia: emerging infectious diseases?
por: Hennenfent, B
Publicado: (1997)

Adherence of Indonesian urologists to practice guidelines for the management of benign prostatic hyperplasia
por: Rahman, Fakhri, et al.
Publicado: (2019)

The Authors Reply: Reply on “Evidence Is Enough?: A Systematic Review and Network Meta-Analysis of the Efficacy of Tamsulosin 0.2 mg and Tamsulosin 0.4 mg as an Initial Therapeutic Dose in Asian Benign Prostatic Hyperplasia Patients”
por: Kim, Su Jin, et al.
Publicado: (2017)

Impact of Benign Prostatic Hyperplasia and/or Prostatitis on the Risk of Prostate Cancer in Korean Patients
por: Kim, Sung Han, et al.
Publicado: (2021)

Zinc status in benign prostatic hyperplasia and prostate carcinoma
por: Wiwanitkit, Somsri, et al.
Publicado: (2012)

Reply to Commentary on “Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea”
por: Jo, Jung Ki, et al.
Publicado: (2021)

Korean Urologist's View of Practice Patterns in Diagnosis and Management of Benign Prostatic Hyperplasia: A Nationwide Survey
por: Oh, Cheol Young, et al.
Publicado: (2010)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia - reply to the letter from Cohen, Peehl and Rosenfeld
por: Mantzoros, CS, et al.
Publicado: (1998)

Authors’ reply
por: Kim, Moosang, et al.
Publicado: (2013)

Authors’ reply
por: Dube, Surya Kumar, et al.
Publicado: (2011)

Clinical Implications of Residual Urine in Korean Benign Prostatic Hyperplasia (BPH) Patients: A Prognostic Factor for BPH-Related Clinical Events
por: Ko, Young Hwii, et al.
Publicado: (2010)

Patterns in the Diagnosis and Management of Benign Prostatic Hyperplasia in a Country that does not have Country-Specific Clinical Practice Guidelines
por: Paick, Jae-Seung, et al.
Publicado: (2007)

Pathophysiology of clinical benign prostatic hyperplasia
por: Foo, Keong Tatt
Publicado: (2017)

Epidemiology of clinical benign prostatic hyperplasia
por: Lim, Kok Bin
Publicado: (2017)

The Urological Society of India guidelines on management of benign prostatic hyperplasia/benign prostatic obstruction (Executive summary)
por: Sabnis, Ravindra Bhalchandra, et al.
Publicado: (2021)

Benign Prostatic Hyperplasia
Publicado: (2015)

Insulin-like growth factor 1 in relation to prostate cancer and benign prostatic hyperplasia.
por: Cohen, P., et al.
Publicado: (1998)

Involvement of Fibroblast Growth Factor Receptor Genes in Benign Prostate Hyperplasia in a Korean Population
por: Park, Hae Jeong, et al.
Publicado: (2013)

Author’s reply to the letter to the editor of Journal of the Korean Association of Oral and Maxillofacial Surgeons
por: Lee, Jeong-Keun
Publicado: (2023)

Authors’ reply
por: Kwon, Ji-Hye, et al.
Publicado: (2022)

Author`s Reply
por: Bae, Jae Seok, et al.
Publicado: (2017)

Is Serenoa repens Effective in the Treatment of Benign Prostatic Hyperplasia?
por: Çeker, Gökhan
Publicado: (2020)

Benign Prostatic Hyperplasia: from Bench to Clinic
por: Yoo, Tag Keun, et al.
Publicado: (2012)

Impact of Intravesical Protrusion of the Prostate in the Treatment of Lower Urinary Tract Symptoms/Benign Prostatic Hyperplasia of Moderate Size by Alpha Receptor Antagonist
por: Seo, Yu Mi, et al.
Publicado: (2012)

Testosterone and benign prostatic hyperplasia
por: Jarvis, Thomas R, et al.
Publicado: (2015)

Effect of Nocturia on Quality of Life among Clients with Benign Prostatic Hyperplasia
por: Varughese, Susamma, et al.
Publicado: (2021)

Commentary on “Changes in Prevalence and Treatment Pattern of Benign Prostatic Hyperplasia in Korea”
por: Shin, Yu Seob, et al.
Publicado: (2021)

Community-based research on the benign prostatic hyperplasia prevalence rate in Korean rural area
por: Goh, Hyeok Jun, et al.
Publicado: (2015)

The Authors Reply
por: Lim, Jeong Uk, et al.
Publicado: (2017)

Letter to the editor: Impact of metabolic syndrome on response to medical treatment of benign prostatic hyperplasia
por: Kadihasanoglu, Mustafa, et al.
Publicado: (2015)

Evaluation of Clinical Outcomes of Prostatic Urethral Lift for Benign Prostatic Hyperplasia: An Asian Population Study
por: Kim, Jeong Ho, et al.
Publicado: (2020)

Association of Metabolic Syndrome and Benign Prostate Enlargement in Young Korean Males
por: Jeong, Jee Hoon, et al.
Publicado: (2011)

It's Time to Take Advantage of Robotic Assisted Simple Prostatectomy in Large Benign Prostatic Hyperplasia
por: Kim, Myong, et al.
Publicado: (2019)

Association of BID SNPs (rs8190315 and rs2072392) and clinical features of benign prostate hyperplasia in Korean population
por: Seok, Hosik, et al.
Publicado: (2014)

Authors' Reply
por: Fluit, C. R. M. G., et al.
Publicado: (2010)

Author's Reply
por: Bhardwaj, Deepali, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_tif1848cj7qqkvrkhoodbkt1ck